ID

43042

Description

A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer (ENTHUSE M0) see http://clinicaltrials.gov/ct2/show/study/NCT00626548

Link

http://clinicaltrials.gov/ct2/show/study/NCT00626548

Keywords

  1. 11/22/11 11/22/11 -
  2. 11/22/11 11/22/11 -
  3. 3/27/14 3/27/14 - Martin Dugas
  4. 4/13/14 4/13/14 - Julian Varghese
  5. 9/17/21 9/17/21 -
Uploaded on

September 17, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility DRKS00003883 NCT00626548 Prostate Cancer

Eligibility NCT00626548

  1. StudyEvent: Eligibility
    1. Eligibility NCT00626548
Inclusion criteria
Description

Inclusion criteria

Alias
UMLS CUI-1
C1512693
18 Years and older
Description

Age

Data type

boolean

Alias
UMLS CUI-1
C0001779
Male
Description

Gender Male

Data type

boolean

Alias
UMLS CUI-1
C0086582
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has NOT spread to the other parts of the body (metastases). Patients with lymph node involvement may be eligible if specified criteria is met.
Description

Prostate Cancer

Data type

boolean

Alias
UMLS CUI-1
C0600139
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
Description

PSA

Data type

boolean

Alias
UMLS CUI-1
C0138741
Currently receiving treatment with surgical or medical castration
Description

Castration

Data type

boolean

Alias
UMLS CUI-1
C0007347
Exclusion criteria
Description

Exclusion criteria

Alias
UMLS CUI-1
C0680251
Currently using opiate based pain killers for cancer related pain
Description

Opiate

Data type

boolean

Alias
UMLS CUI-1
C0376196
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
Description

Previous chemotherapy

Data type

boolean

Alias
UMLS CUI-1
C1514457
Suffering from heart failure or had a myocardial infarction within last 6 months
Description

Heart disease

Data type

boolean

Alias
UMLS CUI-1
C0018799
A history of epilepsy or seizures
Description

Epilepsy

Data type

boolean

Alias
UMLS CUI-1
C0014544

Similar models

Eligibility NCT00626548

  1. StudyEvent: Eligibility
    1. Eligibility NCT00626548
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion criteria
C1512693 (UMLS CUI-1)
Age
Item
18 Years and older
boolean
C0001779 (UMLS CUI-1)
Gender Male
Item
Male
boolean
C0086582 (UMLS CUI-1)
Prostate Cancer
Item
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has NOT spread to the other parts of the body (metastases). Patients with lymph node involvement may be eligible if specified criteria is met.
boolean
C0600139 (UMLS CUI-1)
PSA
Item
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
boolean
C0138741 (UMLS CUI-1)
Castration
Item
Currently receiving treatment with surgical or medical castration
boolean
C0007347 (UMLS CUI-1)
Item Group
Exclusion criteria
C0680251 (UMLS CUI-1)
Opiate
Item
Currently using opiate based pain killers for cancer related pain
boolean
C0376196 (UMLS CUI-1)
Previous chemotherapy
Item
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
boolean
C1514457 (UMLS CUI-1)
Heart disease
Item
Suffering from heart failure or had a myocardial infarction within last 6 months
boolean
C0018799 (UMLS CUI-1)
Epilepsy
Item
A history of epilepsy or seizures
boolean
C0014544 (UMLS CUI-1)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial